REGENXBIO Inc. (RGNX) Social Stream



REGENXBIO Inc. (RGNX): $24.26

-0.12 (-0.49%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add RGNX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 398

in industry

REGENXBIO Inc (RGNX) Price Targets From Analysts

Use the tables below to see what analysts covering REGENXBIO Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 8 $90 $43 $62.75 $35.04 79.08%
2022-01-10 8 $90 $29 $59.25 $35.04 69.09%
2022-02-01 8 $90 $29 $58.25 $35.04 66.24%
2022-02-14 8 $90 $29 $57.5 $35.04 64.1%
2022-03-04 8 $90 $25 $57 $35.04 62.67%
2022-03-22 7 $82 $25 $52.428 $35.04 49.62%
2022-03-29 7 $82 $25 $55.375 $35.04 58.03%

The Trend in the Analyst Price Target


Over the past 23 months, RGNX's average price target has gone down $15.62.

RGNX reports an average of 87.58% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-10 9 100 40 64.380 37.86 70.05%
2021-07-16 9 100 40 64.380 36.26 77.55%
2021-09-08 9 100 40 64.000 33.48 91.16%
2022-01-10 8 90 29 59.250 28.24 109.81%
2022-03-29 7 82 25 55.375 33.35 66.04%

RGNX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.93 3 1 3 0 0 7

The Trend in the Broker Recommendations


RGNX's average broker recommendation rating improved by 0.12 over the prior 151 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • RGNX has a lower variance in analysts' estimates than -628.32% of all US stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, REGENXBIO Inc's average analyst price target is higher than 591.22% of them.
  • In terms of how REGENXBIO Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 218.71% of that group.
  • In the context of Pharmaceutical Products stocks, REGENXBIO Inc's number of analysts covering the stock is greater than 541.55% of them.

Stocks similar to REGENXBIO Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are REPL, PLX, and PCVX.

Is RGNX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.526 seconds.